This New York based company operates in the highly competitive pharmaceutical research and development industry. With a patent-pending compound currently in development, the company is gearing up toward getting their flagship product approved by regulatory bodies in North America. In addition, the company is traded publicly on the NADAQ and relies on market interest when raising capital to drive its operations.